US FDA flags Cipla New York facility inspection with VAI
US FDA classifies Cipla subsidiary’s New York facility inspection as “Voluntary Action Indicated.”
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.